AETHLON MEDICAL, INC. Payments of Stock Issuance Costs
AETHLON MEDICAL, INC. (AEMD) reported Payments of Stock Issuance Costs of $82.57 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- AETHLON MEDICAL, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $82.57K.
- AETHLON MEDICAL, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $66.25K, a 94.31% decline year-over-year.
- AETHLON MEDICAL, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- AETHLON MEDICAL, INC. payments of stock issuance costs for the quarter ending 2025-03-31 was $1.16M.
- AETHLON MEDICAL, INC. payments of stock issuance costs for fiscal 2026 was $1.09M, a 6.53% decline from fiscal 2025.
- AETHLON MEDICAL, INC. payments of stock issuance costs for fiscal 2025 was $1.16M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.57K 10-Q · filed 2026-08-13 | $148.82K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $66.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-10 | $1.09M 10-K · filed 2026-06-10 | ||
| 2025-12-31 | $1.02M 10-Q · filed 2026-02-12 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $1.16M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-10 | $1.16M 10-K · filed 2026-06-10 | ||
| 2024-12-31 | $0.00 10-Q · filed 2026-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |